Precigen (NASDAQ:PGEN) Receives Buy Rating from HC Wainwrigh

HC Wainwright reissued their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, […]

Related Keywords

China , Ohio , United States , Randalj Kirk , , Fisher Asset Management , Sigma Securities , Precigen Inc , Cresset Asset Management , Precigen Company Profile , Securities Exchange Commission , China Universal Asset Management Co , Free Report , Director Randal , Exchange Commission , Asset Management , Employees Retirement System , China Universal Asset Management , Universal Asset Management , Get Free Report , Precigen Daily ,